Gilead execs bag pay hikes, $8 million in bonuses
January 30, 2014 at 19:30 PM EST
While facing cries that its cutting-edge hepatitis and HIV drugs are overpriced, Gilead Sciences Inc...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|